State Street’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,758
| Closed | -$32.3K | – | 4414 |
|
|
2024
Q1 | $32.3K | Hold |
3,758
| – | – | ﹤0.01% | 4228 |
|
|
2023
Q4 | $13.2K | Hold |
3,758
| – | – | ﹤0.01% | 4378 |
|
|
2023
Q3 | $13.4K | Hold |
3,758
| – | – | ﹤0.01% | 4482 |
|
|
2023
Q2 | $21.9K | Hold |
3,758
| – | – | ﹤0.01% | 4583 |
|
|
2023
Q1 | $142K | Hold |
3,758
| – | – | ﹤0.01% | 4189 |
|
|
2022
Q4 | $112K | Hold |
3,758
| – | – | ﹤0.01% | 4339 |
|
|
2022
Q3 | $126K | Hold |
3,758
| – | – | ﹤0.01% | 4368 |
|
|
2022
Q2 | $150K | Hold |
3,758
| – | – | ﹤0.01% | 4340 |
|
|
2022
Q1 | $198K | Buy |
3,758
+110
| +3% | +$5.8K | ﹤0.01% | 4390 |
|
|
2021
Q4 | $202K | Hold |
3,648
| – | – | ﹤0.01% | 4349 |
|
|
2021
Q3 | $282K | Hold |
3,648
| – | – | ﹤0.01% | 4226 |
|
|
2021
Q2 | $473K | Buy |
+3,648
| New | +$473K | ﹤0.01% | 3878 |
|